First New York Securities’s Globus Medical GMED Stock Holding History

First New York Securities’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,800	Closed	-$161K	–	141
2015 Q3	$161K	Buy	+7,800	New	+$198K	0.07%	88

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First New York Securities's GMED Position: Q4 2015 in Review

First New York Securities sold out of Globus Medical (GMED) in Q4 2015, closing a stake of 7,800 shares — an estimated $161K sold.

First New York Securities first reported a position in GMED in Q3 2015 and held it in 1 quarter. The position peaked at $161K in Q3 2015. 191 funds tracked by Wall St. Rank hold GMED as of Q4 2015.

First New York Securities reported no remaining Globus Medical position as of Q4 2015 after selling out during the quarter.
First New York Securities sold 7,800 Globus Medical shares in Q4 2015, an estimated $161K.
First New York Securities first reported a position in Globus Medical in Q3 2015 and held it in 1 quarter.
First New York Securities's Globus Medical position peaked at $161K in Q3 2015.
191 funds tracked by Wall St. Rank held Globus Medical as of Q4 2015.

Based on First New York Securities's 13F filing for Q4 2015, filed 25 Jan 2016.